Canada's approach to SARS-CoV-2 sero-surveillance: Lessons learned for routine surveillance and future pandemics.

IF 2.9 4区 医学 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Sheila F O'Brien, Michael Asamoah-Boaheng, Brian Grunau, Mel Krajden, David L Buckeridge, David M Goldfarb, Maureen Anderson, Marc Germain, Patrick Brown, Derek R Stein, Kami Kandola, Graham Tipples, Philip Awadalla, Amanda Lang, Lesley Behl, Tiffany Fitzpatrick, Steven J Drews
{"title":"Canada's approach to SARS-CoV-2 sero-surveillance: Lessons learned for routine surveillance and future pandemics.","authors":"Sheila F O'Brien, Michael Asamoah-Boaheng, Brian Grunau, Mel Krajden, David L Buckeridge, David M Goldfarb, Maureen Anderson, Marc Germain, Patrick Brown, Derek R Stein, Kami Kandola, Graham Tipples, Philip Awadalla, Amanda Lang, Lesley Behl, Tiffany Fitzpatrick, Steven J Drews","doi":"10.17269/s41997-024-00901-w","DOIUrl":null,"url":null,"abstract":"<p><strong>Setting: </strong>In Canada's federated healthcare system, 13 provincial and territorial jurisdictions have independent responsibility to collect data to inform health policies. During the COVID-19 pandemic (2020-2023), national and regional sero-surveys mostly drew upon existing infrastructure to quickly test specimens and collect data but required cross-jurisdiction coordination and communication.</p><p><strong>Intervention: </strong>There were 4 national and 7 regional general population SARS-CoV-2 sero-surveys. Survey methodologies varied by participant selection approaches, assay choices, and reporting structures. We analyzed Canadian pandemic sero-surveillance initiatives to identify key learnings to inform future pandemic planning.</p><p><strong>Outcomes: </strong>Over a million samples were tested for SARS-CoV-2 antibodies from 2020 to 2023 but siloed in 11 distinct datasets. Most national sero-surveys had insufficient sample size to estimate regional prevalence; differences in methodology hampered cross-regional comparisons of regional sero-surveys. Only four sero-surveys included questionnaires. Sero-surveys were not directly comparable due to different assays, sampling methodologies, and time-frames. Linkage to health records occurred in three provinces only. Dried blood spots permitted sample collection in remote populations and during stay-at-home orders.</p><p><strong>Implications: </strong>To provide timely, high-quality information for public health decision-making, routine sero-surveillance systems must be adaptable, flexible, and scalable. National capability planning should include consortiums for assay design and validation, defined mechanisms to improve test capacity, base documents for data linkage and material transfer across jurisdictions, and mechanisms for real-time communication of data. Lessons learned will inform incorporation of a robust sero-survey program into routine surveillance with strategic sampling and capacity to adapt and scale rapidly as a part of a comprehensive national pandemic response plan.</p>","PeriodicalId":51407,"journal":{"name":"Canadian Journal of Public Health-Revue Canadienne De Sante Publique","volume":null,"pages":null},"PeriodicalIF":2.9000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11382644/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canadian Journal of Public Health-Revue Canadienne De Sante Publique","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.17269/s41997-024-00901-w","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/9 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

Abstract

Setting: In Canada's federated healthcare system, 13 provincial and territorial jurisdictions have independent responsibility to collect data to inform health policies. During the COVID-19 pandemic (2020-2023), national and regional sero-surveys mostly drew upon existing infrastructure to quickly test specimens and collect data but required cross-jurisdiction coordination and communication.

Intervention: There were 4 national and 7 regional general population SARS-CoV-2 sero-surveys. Survey methodologies varied by participant selection approaches, assay choices, and reporting structures. We analyzed Canadian pandemic sero-surveillance initiatives to identify key learnings to inform future pandemic planning.

Outcomes: Over a million samples were tested for SARS-CoV-2 antibodies from 2020 to 2023 but siloed in 11 distinct datasets. Most national sero-surveys had insufficient sample size to estimate regional prevalence; differences in methodology hampered cross-regional comparisons of regional sero-surveys. Only four sero-surveys included questionnaires. Sero-surveys were not directly comparable due to different assays, sampling methodologies, and time-frames. Linkage to health records occurred in three provinces only. Dried blood spots permitted sample collection in remote populations and during stay-at-home orders.

Implications: To provide timely, high-quality information for public health decision-making, routine sero-surveillance systems must be adaptable, flexible, and scalable. National capability planning should include consortiums for assay design and validation, defined mechanisms to improve test capacity, base documents for data linkage and material transfer across jurisdictions, and mechanisms for real-time communication of data. Lessons learned will inform incorporation of a robust sero-survey program into routine surveillance with strategic sampling and capacity to adapt and scale rapidly as a part of a comprehensive national pandemic response plan.

加拿大的 SARS-CoV-2 血清监测方法:常规监测和未来流行病的经验教训。
背景:在加拿大的联邦医疗保健系统中,13 个省和地区辖区有收集数据的独立责任,以便为卫生政策提供信息。在 COVID-19 大流行期间(2020-2023 年),国家和地区血清调查大多利用现有基础设施快速检测标本和收集数据,但需要跨辖区协调和沟通:共进行了 4 次全国性和 7 次地区性普通人群 SARS-CoV-2 血清调查。调查方法因参与者选择方法、检测方法选择和报告结构而异。我们分析了加拿大的大流行病血清监测措施,以找出关键的经验教训,为未来的大流行病规划提供参考:从 2020 年到 2023 年,对超过 100 万份样本进行了 SARS-CoV-2 抗体检测,但这些样本分散在 11 个不同的数据集中。大多数国家血清调查的样本量不足以估计地区流行率;方法上的差异妨碍了地区血清调查的跨地区比较。只有四项血清调查包括问卷调查。由于检测方法、采样方法和时间范围不同,血清调查不能直接进行比较。只有三个省份与健康记录建立了联系。干血点允许在偏远人群和在家待产期间采集样本:要为公共卫生决策提供及时、高质量的信息,常规血清监测系统必须具有适应性、灵活性和可扩展性。国家能力规划应包括化验设计和验证联合体、提高检验能力的明确机制、跨辖区数据链接和材料转移的基础文件以及数据实时通信机制。汲取的经验教训将为将一个强大的血清调查计划纳入常规监测提供信息,该计划具有战略性采样以及快速适应和扩展的能力,是国家大流行综合应对计划的一部分。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Canadian Journal of Public Health-Revue Canadienne De Sante Publique
Canadian Journal of Public Health-Revue Canadienne De Sante Publique PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-
CiteScore
6.10
自引率
4.70%
发文量
128
期刊介绍: The Canadian Journal of Public Health is dedicated to fostering excellence in public health research, scholarship, policy and practice. The aim of the Journal is to advance public health research and practice in Canada and around the world, thus contributing to the improvement of the health of populations and the reduction of health inequalities. CJPH publishes original research and scholarly articles submitted in either English or French that are relevant to population and public health. CJPH is an independent, peer-reviewed journal owned by the Canadian Public Health Association and published by Springer.   Énoncé de mission La Revue canadienne de santé publique se consacre à promouvoir l’excellence dans la recherche, les travaux d’érudition, les politiques et les pratiques de santé publique. Son but est de faire progresser la recherche et les pratiques de santé publique au Canada et dans le monde, contribuant ainsi à l’amélioration de la santé des populations et à la réduction des inégalités de santé. La RCSP publie des articles savants et des travaux inédits, soumis en anglais ou en français, qui sont d’intérêt pour la santé publique et des populations. La RCSP est une revue indépendante avec comité de lecture, propriété de l’Association canadienne de santé publique et publiée par Springer.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信